Press release
Protheragen Looks to Accelerate Autoimmune Disease Therapy by Offering Animal Model Development Services
New York, USA - September 11, 2024 - To advance research in autoimmune diseases, Protheragen announces the launch of its professional animal model development services. These services are designed to accelerate the development of innovative therapies for autoimmune diseases by providing researchers with customized animal models for preclinical testing.
Image: https://www.getnews.info/uploads/f3689327e4f7f26d5f10eb2654202775.jpg
Autoimmune diseases are complex conditions that occur when the immune system mistakenly attacks the body's own tissues and organs. These diseases can be debilitating and challenging to treat, making them a significant focus of biomedical research and drug development efforts. To better understand the underlying mechanisms of autoimmune diseases and develop effective treatments, animal models are often used to mimic specific aspects of these conditions, providing valuable insights into the pathogenesis of autoimmune diseases and helping identify potential therapeutic targets.
With extensive expertise in immunology and biotechnology, Protheragen can provide researchers with high-quality, reliable models that closely replicate human autoimmune diseases. By combining innovative genetic engineering techniques (CRISPR/CAS9) and immunological insights, the company can develop relevant and predictive models for various autoimmune disorders including asthma, atopic dermatitis, type 1 diabetes, and psoriasis. Additionally, Protheragen can also offer chemically induced animal models, such as colitis and rheumatoid arthritis models. To validate the fidelity of autoimmune animal models [https://www.autoimmunetec.com/animal-models-development-service.html], Protheragen will conduct rigorous phenotypic and genotypic evaluations to ensure that the generated models exhibit the desired disease traits and pathological manifestations.
By offering customized animal models that closely reproduce the pathophysiology of autoimmune diseases, Protheragen hopes to empower global clients to advance their research and develop innovative therapies. Now, its animal model development services are available to researchers in the biopharmaceutical industry, academia, and government organizations. With a dedicated team of experts and state-of-the-art facilities, Protheragen is committed to providing the highest quality models and exceptional customer service.
About Protheragen
Protheragen is dedicated to meeting preclinical research needs in the study of autoimmune diseases. Whether researchers are conducting studies on new or modified medications, medical devices or therapeutic regimes for autoimmune diseases, Protheragen is here to help. With its skilled technical team and top-notch platform, the company can offer a wide range of autoimmune disease models, solutions for diagnostic development, and professional autoimmune disease services [https://www.autoimmunetec.com/] to expedite autoimmune disease research efforts.
Media Contact
Company Name: Protheragen
Contact Person: Media Relations
Email: Send Email [http://www.universalpressrelease.com/?pr=protheragen-looks-to-accelerate-autoimmune-disease-therapy-by-offering-animal-model-development-services]
Phone: 1-631-371-3915
Country: United States
Website: https://www.autoimmunetec.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Protheragen Looks to Accelerate Autoimmune Disease Therapy by Offering Animal Model Development Services here
News-ID: 3652554 • Views: …
More Releases from Getnews
Spectrum Electric Redefines What It Means to Be a Full-Service Electrical Partne …
Image: https://www.globalnewslines.com/uploads/2025/12/f1b1018646e29745b0c22c200a9eee9e.jpg
Spectrum Electric, a Central Florida-based electrical contractor led by CEO Richard Forthman, is gaining regional attention for its proactive, client-focused approach to electrical service and commercial construction.
With more than 15 years in business and significant growth under Forthman's leadership over the past eight years, Spectrum Electric has positioned itself as an up-and-coming regional leader in the electrical contracting industry. While the company maintains a strong residential and service footprint…
The U.S. Green Card: Turning a Temporary Stay into a Permanent American Future
Image: https://www.globalnewslines.com/uploads/2025/12/1766183100.jpg
For many people, a U.S. visa is only the beginning. What they truly want is certainty - the ability to live, work, and plan their future in the United States without expiry dates, renewals, or ongoing fear that a single decision could unravel years of effort.
That certainty is called a Green Card.
Yet despite its importance, the Green Card [https://larhdellaw.com/] process is often misunderstood. Some believe it is only for…
The L-1 Visa: How Global Businesses Expand to the U.S. Without Starting From Scr …
Image: https://www.globalnewslines.com/uploads/2025/12/1766182907.jpg
For international companies with ambitions to enter the United States, few visa options are as powerful - or as misunderstood - as the L-1 Intracompany Transfer Visa.
When used correctly, the L-1 visa allows established businesses to expand into the U.S. market, transfer trusted senior staff, and build a long-term American presence without relying on lotteries, third-party sponsors, or speculative investment routes. When used incorrectly, it becomes one of the…
The B-1/B-2 Visitor Visa: Why Careful Preparation Matters More Than Ever
Image: https://www.globalnewslines.com/uploads/2025/12/1766182346.jpg
The B-1/B-2 visitor visa [https://larhdellaw.com/]is often described as the most common U.S. visa. That description, while true, can be misleading. Its familiarity causes many applicants to underestimate how closely these visas are scrutinised - and how easily an application can be refused.
In today's immigration environment, visitor visas are assessed with a level of caution that surprises even experienced international travellers. The rules themselves have not dramatically changed, but how…
More Releases for Protheragen
Protheragen Expands 13C/14C-Labeled Compound Portfolio for Metabolic and Pharmac …
Protheragen offers a wider variety of 13C/14C-labeled compounds, supporting research in metabolic pathways, pharmacokinetics, breath assays, and biochemical tracing.
New York, USA - November 12, 2025 - Protheragen has expanded its 13C/14C-labeled compound portfolio to support research in metabolic pathways, pharmacokinetics, breath assays, and biochemical tracing. The expanded lineup improves options for high-accuracy molecular tracing and supports consistent data output in metabolism and drug distribution research. Researchers can now explore a…
Protheragen Introduces Comprehensive Drug Analysis Services for Pharmaceutical D …
Protheragen, a leading biotechnology company, provides effective Drug Analysis [https://www.protheragen.ai/drug-analysis.html] services that help pharmaceutical researchers and manufacturers. In drug research, drug analysis is useful for the safety, efficacy, and quality of drugs. With advanced technologies and scientific expertise, Protheragen's analytical solutions play an important role in drug development.
Drug Analysis includes many analytical procedures designed to evaluate various properties of pharmaceutical compounds. These analyses are important for understanding drug characteristics and…
Protheragen Launches One-stop Services for Rare Blood Diseases
Protheragen, a leading provider of life sciences research and development solutions, announces its innovative One-stop Services [https://www.protheragen.us/blood-disorders/our-services.html] platform designed to accelerate therapeutic discoveries and development across blood disease areas. This platform integrates advanced technologies with expert scientific consultation. The streamlined workflow can better address the challenges in research.
"Our integrated approach allows clients to handle the issues of drug development with heightened accuracy and operational efficiency," explains a senior scientist from…
Protheragen Unveils Revolutionary EndureCAR-T Trademark Cell Therapy Platform
Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models.
Protheragen is an advanced CAR-T cell therapy service provider. With its extensive experience in cell therapy development and EndureCART Trademark technology platform, Protheragen provides investigators a wide range of disease models to ensure detailed and customized treatment methods for superior therapeutic outcomes.
With the development of immunology, scientists…
Protheragen Announces GeniusAb Trademark : A Fully Human Single-Domain Antibody …
New York, United States - Protheragen has launched GeniusAb Trademark [https://www.geniusab.com/], a fully human single-domain antibody platform to produce high quality and customized antibodies for research, diagnostic and therapeutic use. This is a major breakthrough in the field of therapeutic antibodies as it is able to provide highly specific, robust, and versatile solutions to a variety of diseases.
Single-domain antibodies (sdAbs), also known as VHH antibodies or camelid antibodies, are derived…
Diving Deeper in Rare Disease Research: Protheragen Unveils Diagnostic Developme …
Protheragen announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research.
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development [https://www.protheragen.us/]. These diagnostic services are designed to support the scientific community in identifying, understanding, and ultimately treating rare diseases that affect millions…
